Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation

被引:33
作者
Dai, Zhi Feng [1 ]
Ma, Xu Yuan [2 ]
Yang, Rui Lin [1 ]
Wang, Hui Chao [3 ]
Xu, Dan Dan [4 ]
Yang, Jing Nan [1 ]
Guo, Xiao Bing [5 ]
Meng, Shuang Shuang [1 ]
Xu, Rui [1 ]
Li, Yu Xia [1 ]
Xu, Yao [1 ]
Li, Kun [6 ]
Lin, Xu Hong [1 ]
机构
[1] Henan Univ, Translat Med Ctr, Dept Clin Lab, Huaihe Hosp, 115 X Men St, Kaifeng 475000, Henan, Peoples R China
[2] Peoples Hosp Xuchang, Dept Gastroenterol, Xuchang 461000, Henan, Peoples R China
[3] Henan Univ, Dept Nephrol, Affiliated Hosp 1, Kaifeng 475000, Henan, Peoples R China
[4] Henan Univ, Dept Dermatol, Huaihe Hosp, Kaifeng 475000, Henan, Peoples R China
[5] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou 450002, Henan, Peoples R China
[6] Tongji Univ, Inst Digest Dis, Dept Pathophysiol, Sch Med, Shanghai 200092, Peoples R China
基金
中国国家自然科学基金;
关键词
ulcerative colitis; intestinal bacteria; inflammation; interleukin-17; interleukin-23; BOWEL-DISEASE; FECAL MICROBIOTA; CROHNS-DISEASE; GUT MICROBIOTA; MUCOSAL FLORA; DIVERSITY; PROBIOTICS; BACTERIAL; TIME; MICROFLORA;
D O I
10.3892/etm.2021.10757
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ulcerative colitis (UC), which is a type of inflammatory bowel disease, is a chronic intestinal disorder of multifactorial etiology. Numerous studies have indicated an association between UC and intestinal bacteria. However, a limited number of studies regarding the expression of interleukin-17 (IL-17) and interleukin-23 (IL-23) in association with intestinal bacteria have been performed. The aim of the current study was to investigate the gut microbiota alterations in patients with UC, at a number of taxonomic levels, and their relationship with intestinal inflammation by analyzing the protein expression of IL-17 and IL-23. Specimens were collected from 10 healthy controls and 16 patients with UC. A histological examination was performed in colonic tissues, IL-17 and IL-23 protein expression was detected by immunohistochemistry, fecal samples were sequenced using 16S rDNA sequencing and bioinformatics analysis was performed. The UC group exhibited an increased histological score (P<0.01) and upregulated IL-17 and IL-23 expression (P<0.01). At the order level, the bacterial diversity of the UC group was decreased. beta-diversity analyses, including principal component analysis, principal coordinate analysis and non-metric multidimensional scaling, demonstrated that the two groups of samples were separated into two taxonomic categories, as distinct variations were observed in the analysis of group differences (P=0.001). Regarding the differences in species composition between the groups, Enterococcus was indicated to be the species with the greatest difference in abundance compared with the healthy control group (P<0.01), followed by Lactobacillus (P<0.05), Escherichia-Shigella (P<0.05), Bifidobacterium and Bacteroides. In addition, the average optical density of IL-17 was positively correlated with the histological score (rho=0.669; P=0.035), Enterococcus (r=0.843; P<0.001), Lactobacillus (r=0.737; P=0.001), Bifidobacterium (r=0.773; P<0.001) and Escherichia-Shigella (r=0.663; P=0.005), and the average optical density of IL-23 was positively correlated with the histological score (rho=0.733; P=0.016), Enterococcus (r=0.771; P<0.001), Lactobacillus (r=0.566; P=0.022), Bifidobacterium (r=0.517; P=0.041) and Escherichia-Shigella (r=0.613; P=0.012). The results of the present study indicated that the intestinal microbiota of patients with UC differed from that of healthy controls at multiple taxonomic levels. The alterations of the intestinal microflora were closely associated with the degree of inflammation. The IL-23/IL-17 axis, as a key factor in the development of UC, maybe associated with the alterations of intestinal microflora. The interaction between intestinal microflora and the IL-23/IL-17 axis may serve an important role in the pathogenesis of UC.
引用
收藏
页数:12
相关论文
共 79 条
[1]  
Adams SM, 2013, AM FAM PHYSICIAN, V87, P699
[2]   The Gut Microbiota and Inflammation: An Overview [J].
Al Bander, Zahraa ;
Nitert, Marloes Dekker ;
Mousa, Aya ;
Naderpoor, Negar .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (20) :1-22
[3]  
[Anonymous], 2008, CHIN J INTERN MED, V47, P73
[4]   Effects of a Lactobacillus reuteri BR11 Mutant Deficient in the Cystine-Transport System in a Rat Model of Inflammatory Bowel Disease [J].
Atkins, Haydn L. ;
Geier, Mark S. ;
Prisciandaro, Luca D. ;
Pattanaik, Ashok K. ;
Forder, Rebecca E. A. ;
Turner, Mark S. ;
Howarth, Gordon S. .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (03) :713-719
[5]   Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis [J].
Bajer, Lukas ;
Kverka, Miloslav ;
Kostovcik, Martin ;
Macinga, Peter ;
Dvorak, Jiri ;
Stehlikova, Zuzana ;
Brezina, Jan ;
Wohl, Pavel ;
Spicak, Julius ;
Drastich, Pavel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) :4548-4558
[6]   Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice [J].
Balish, E ;
Warner, T .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2253-2257
[7]  
Bamola V. Deepak, 2017, Microbial Ecology in Health and Disease, V28, P1322447, DOI 10.1080/16512235.2017.1322447
[8]   The Intestinal Microbiota in Inflammatory Bowel Disease [J].
Becker, Christoph ;
Neurath, Markus F. ;
Wirtz, Stefan .
ILAR JOURNAL, 2015, 56 (02) :192-204
[9]   Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions [J].
Clarke, Gerard ;
Sandhu, Kiran, V ;
Griffin, Brendan T. ;
Dinan, Timothy G. ;
Cryan, John F. ;
Hyland, Niall P. .
PHARMACOLOGICAL REVIEWS, 2019, 71 (02) :198-224
[10]   RETRACTED: The Microbiota in Inflammatory Bowel Disease in Different Age Groups (Retracted article. See vol. 32, pg. 312, 2014) [J].
Cucchiara, Salvatore ;
Iebba, Valerio ;
Conte, Maria Pia ;
Schippa, Serena .
DIGESTIVE DISEASES, 2009, 27 (03) :252-258